Chromosomal Analysis of Single Cells in Human Embryos

• Sponsor: KU Leuven (Other)
• Overall Status: Unknown status
• CT.gov ID: NCT00614367
• Collaborator: (none)
• Enrollment: 30
• Location: 1
• Duration (Months): 32
• Patients Per Site Per Month: 0.9

Study Details

Study Description

Brief Summary

Optimise genetic screening of human embryos using higher resolution techniques

Condition or Disease	Intervention/Treatment	Phase
Chromosomal Abnormalities

Study Design

• Study Type: Observational
• Actual Enrollment: 30 participants
• Time Perspective: Prospective
• Official Title: Chromosomal Analysis of Single Cells in Human Embryos
• Study Start Date: Oct 1, 2005
• Anticipated Primary Completion Date: Mar 1, 2008
• Anticipated Study Completion Date: Jun 1, 2008

Outcome Measures

Primary Outcome Measures

1. genetic constitution of single blastomeres [3 day old embryos]

Eligibility Criteria

Criteria

• Ages Eligible for Study: 3 Days to 4 Days
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• 3-4 day old embryos from IVF couples with both partners younger than 36 years old

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	University Hospital Leuven, Catholic University Leuven	Leuven		Belgium	3000

Sponsors and Collaborators

• KU Leuven

Investigators

• Principal Investigator: Joris Vermeesch, Prof PhD, University Hospital Leuven, Catholic University Leuven
• Study Director: Thomas D'hooghe, Prof MD PhD, Universitaire Ziekenhuizen Leuven

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• ClinicalTrials.gov Identifier: NCT00614367
• Other Study ID Numbers: ML4102005
• First Posted: Feb 13, 2008
• Last Update Posted: Feb 13, 2008
• Last Verified: Jan 1, 2008

• Keywords provided by , ,: chromosomal abnormalities in single cells
• Additional relevant MeSH terms: Congenital Abnormalities; Chromosome Disorders; Chromosome Aberrations

Study Results

No Results Posted as of Feb 13, 2008